Bionyra Pharma is a clinical-stage biopharmaceutical company focused on developing next-generation biologics for immune-mediated inflammatory diseases. Its pipeline includes mono and multispecific antibodies designed to modulate key immune pathways and deliver deeper, more durable clinical responses.